Skip to content
healthcare.dev

CeraVe Developed with Dermatologists BHA Exfoliating Toner Acne Treatment

NDC 82046-291, Salicylic acid, liquid, from L'Oreal USA Products Inc.

Product NDC
82046-291
Status
Listed
Labeler
L'Oreal USA Products Inc
Dosage form
LIQUID
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M006
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82046-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SALICYLIC ACID20 mg/mL
Package NDCNDC-11Package
82046-291-0182046029101237 mL in 1 BOTTLE (82046-291-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 82046-291 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82046-291 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82046-291. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.